Clinical Trials Logo

Clinical Trial Summary

The SCIentinel-prolong study systematically analyzes humoral autoantibody responses and thier interaction with post-spinal cord injury (SCI) immune-deficiency and infections as well as their association with the clinical course of rehabilitation. Therefore, molecular and immunological tests in blood and cerebrospinal fluid specimen are combined with clinical outcomes ranging from neurological function, neuropathic pain and spasticity to walking tests and measures of independence in daily living within the first year after SCI. Including a control group with participants suffering from vertebral fractures without SCI allows to differentiate between neurological and general injury and treatment effects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04211636
Study type Observational
Source Charite University, Berlin, Germany
Contact Marcel A Kopp, MD
Phone +49 30 450560075
Email marcel.kopp@charite.de
Status Not yet recruiting
Phase
Start date October 2023
Completion date April 2026

See also
  Status Clinical Trial Phase
Terminated NCT00879021 - Study of Pregabalin in the Prevention of Central Neuropathic Pain in Acute Spinal Cord Injury Phase 3
Completed NCT00654082 - A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction Phase 4
Terminated NCT03089749 - Characterization of Human Autoantibody Titers After Central Nervous System Insult
Completed NCT02302157 - Dose Escalation Study of AST-OPC1 in Spinal Cord Injury Phase 1/Phase 2
Completed NCT01321333 - Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury Phase 1/Phase 2
Completed NCT02201173 - Health Outcomes After Locomotor Training in Spinal Cord Injury N/A
Recruiting NCT04460872 - Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury Phase 2
Completed NCT04378218 - Cardiovascular Effects of High Intensity Interval Training in Individuals With Paraplegia N/A